Skip to main navigation Skip to search Skip to main content

Atomic Layer Deposition Processes: Versatile Platforms for Engineering ZnO‐Chitosan Biointerfaces

  • Mabel Moreno
  • , Anjana Devi
  • , David Zanders
  • , Miryam Arredondo
  • , Davide Mariotti
  • , Ruairi McGlynn
  • , Sindy Devis
  • , Simón Guerrero
  • , Eglantina Benavente
  • , Matias Alegría
  • , Yusser Olguin
  • , Lorena Lobos‐Gonzalez
  • , Kevin Guzmán
  • , Elizabeth Rivas‐Yañez
  • , Paula Solar
  • , Valentin Cepus
  • , Michael Krause
  • , Luis Velásquez

Research output: Contribution to journalArticlepeer-review

12 Downloads (Pure)

Abstract

This study explores zinc-functionalized chitosan (CS) for engineering bio-multifunctional interfaces via three atomic-scale techniques: vapor phase metalation (VPM), multiple pulsed vapor phase infiltration (MPI), and O2 plasma-enhanced atomic layer deposition (PEALD). X-ray photoelectron spectroscopy (XPS) analysis and scanning electron microscopy (SEM) with integrated energy-dispersive X-ray (EDX) elemental mapping confirmed homogeneous Zn distribution in all regimes, while AFM revealed a topographical transition from planarization in VPM (Rq = 5.6 nm) to high-surface-area nucleation in MPI (Rq = 123.9 nm). X-ray diffraction (XRD) analysis demonstrated structural reconfiguration, with VPM reducing the hydrated phase crystallite size (7.4 to 4.6 nm) and MPI achieving the finest nanocrystallinity (1.83 nm). Notably, PEALD-modified interfaces exhibited the highest interfacial energy (0.102 J/m2) and enhanced swelling. Physicochemical characterization showed the functionalization method dictates semiconductor properties, while biological assays revealed C2C12 cell proliferation comparable to the control, along with tailored antiseptic activity against E. coli and H. pylori. Significantly, in vivo subcutaneous implantation revealed that CS-ZnO PEALD scaffolds act as immunomodulatory interfaces, promoting active angiogenesis and a balanced immune response with stable anti-inflammatory IL-10 levels and near-basal pro-inflammatory expression (IL-6 = 0.5 pg/mL). These findings highlight the versatility of ALD-based processes for next-generation intelligent medical implants and bio-integrated electronics.
Original languageEnglish
Article numbere71329
Pages (from-to)1-23
Number of pages23
JournalAdvanced Healthcare Materials
Volume15
Issue number26
Early online date17 Jun 2026
DOIs
Publication statusPublished (in print/issue) - 10 Jul 2026

Bibliographical note

The authors thank the National Fund for Scientific and Technological Development (FONDECY)/1171803 Chile.

Publisher Copyright:
© 2026 The Author(s). Advanced Healthcare Materials published by Wiley-VCH GmbH.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Funding

This work was supported by National Fund for Scientific and Technological Development (FONDECY)/1171803 Chile, EPSRC (EP/V055232/1, EP/R008841/1), and FONDECYT 1240757 and ANID PIA / APOYO AFB230003

Keywords

  • antiseptic ZnO coatings
  • in vivo integration
  • ALD techniques
  • angiogenesis
  • chitosan
  • biocompatibility

Fingerprint

Dive into the research topics of 'Atomic Layer Deposition Processes: Versatile Platforms for Engineering ZnO‐Chitosan Biointerfaces'. Together they form a unique fingerprint.

Cite this